Other prognostic markers, which have been established but mainly concern symptomatic CLL patients, are lymphocyte CD38 expression, presence of ZAP-70, immunoglobulin (Ig) heavy gene mutation status, and cytogenetic profile [1–6]. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.